Tcg Crossover Management, LLC

Investment Portfolio & 13F Holdings Analysis

About

Type: FundHoldings: 38Value: $733.1MLatest: 2025Q1

TCG Crossover Management, LLC is an institutional investment manager that filed its latest Form 13F for 2025Q1, reporting 38 holdings worth $0.7 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.

AI_NATIVE detailed information: This accession holds the following tickers:[
  "OCUL",
  "CNTA",
  "NKTR",
  "ABVX",
  "ATXS",
  "TNGX",
  "GPCR",
  "SLN",
  "SVRA",
  "THRD",
  "TRML",
  "TYRA",
  "MLYS",
  "KROS",
  "ADVM",
  "AVTX",
  "AMLX",
  "FULC",
  "UPB",
  "RAPT",
  "MBX",
  null,
  "SLNO",
  "COGT",
  "DYN",
  "CMPS",
  "CDTX",
  "EYPT",
  "KURA",
  "KOD",
  "VTYX",
  "VTGN",
  "TRDA",
  "XNCR",
  "CABA",
  "CGON",
  "DNTH",
  "IRON"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-14
Total Holdings: 38
Total Value: 733085569
Accession Number: 0001214659-25-007553
Form Type: 13F-HR
CIK: tcg-crossover-management
Manager Name: Tcg-Crossover-Management

Data Enrichment

97% identified

37 identified1 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

38 positions • $733.1M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 1 of 2

Sort by:

CG Oncology, Inc.

CGON|156944100

Shares:3.7M

Value:$89.9M

% of Portfolio:12.3% ($89.9M/$733.1M)

Cogent Biosciences, Inc.

COGT|19240Q201

Shares:7.0M

Value:$41.7M

% of Portfolio:5.7% ($41.7M/$733.1M)

Centessa Pharmaceuticals plc

CNTA|152309100

Shares:2.9M

Value:$41.6M

% of Portfolio:5.7% ($41.6M/$733.1M)

Mineralys Therapeutics, Inc.

MLYS|603170101

Shares:2.5M

Value:$39.2M

% of Portfolio:5.4% ($39.2M/$733.1M)

OCULAR THERAPEUTIX, INC

OCUL|67576A100

Shares:5.3M

Value:$39.0M

% of Portfolio:5.3% ($39.0M/$733.1M)

Abivax S.A.

ABVX|00370M103

Shares:6.1M

Value:$37.9M

% of Portfolio:5.2% ($37.9M/$733.1M)

Savara Inc

SVRA|805111101

Shares:12.4M

Value:$34.2M

% of Portfolio:4.7% ($34.2M/$733.1M)

Dyne Therapeutics, Inc.

DYN|26818M108

Shares:2.7M

Value:$27.7M

% of Portfolio:3.8% ($27.7M/$733.1M)

Dianthus Therapeutics, Inc. /DE/

DNTH|252828108

Shares:1.5M

Value:$27.2M

% of Portfolio:3.7% ($27.2M/$733.1M)

Tyra Biosciences, Inc.

TYRA|90240B106

Shares:2.9M

Value:$27.0M

% of Portfolio:3.7% ($27.0M/$733.1M)

Xencor Inc

XNCR|98401F105

Shares:2.5M

Value:$26.1M

% of Portfolio:3.6% ($26.1M/$733.1M)

Disc Medicine, Inc.

IRON|254604101

Shares:465.3K

Value:$23.1M

% of Portfolio:3.2% ($23.1M/$733.1M)

Tourmaline Bio, Inc.

TRML|89157D105

Shares:1.5M

Value:$22.5M

% of Portfolio:3.1% ($22.5M/$733.1M)

Cidara Therapeutics, Inc.

CDTX|171757206

Shares:1.0M

Value:$21.7M

% of Portfolio:3.0% ($21.7M/$733.1M)

Amylyx Pharmaceuticals, Inc.

AMLX|03237H101

Shares:5.9M

Value:$21.0M

% of Portfolio:2.9% ($21.0M/$733.1M)

SOLENO THERAPEUTICS INC

SLNO|834203309

Shares:275.0K

Value:$19.6M

% of Portfolio:2.7% ($19.6M/$733.1M)

EyePoint Pharmaceuticals, Inc.

EYPT|30233G209

Shares:3.6M

Value:$19.4M

% of Portfolio:2.6% ($19.4M/$733.1M)

Structure Therapeutics Inc.

GPCR|86366E106

Shares:1.1M

Value:$18.4M

% of Portfolio:2.5% ($18.4M/$733.1M)

Upstream Bio, Inc.

UPB|91678A107

Shares:2.8M

Value:$17.1M

% of Portfolio:2.3% ($17.1M/$733.1M)

RAPT Therapeutics, Inc.

RAPT|75382E109

Shares:13.1M

Value:$16.0M

% of Portfolio:2.2% ($16.0M/$733.1M)

Instrument	Shares		Other Manager	Value	% of Portfolio
CG Oncology, Inc.(CGONcusip156944100)	3.7M	QoQ 0.00% (-0) YoY +2.80% (-100.0K)	All Managers (Combined)	$89.9M	12.3% ($89.9M/$733.1M)	QoQ -14.60% (-$15.4M) YoY -42.65% (-$66.8M)
Cogent Biosciences, Inc.(COGTcusip19240Q201)	7.0M	QoQ 0.00% (-0) YoY +12.06% (-750.0K)	All Managers (Combined)	$41.7M	5.7% ($41.7M/$733.1M)	QoQ -23.20% (-$12.6M) YoY -0.10% (-$44.0K)
Centessa Pharmaceuticals plc(CNTAcusip152309100)	2.9M	QoQ 0.00% (-0) YoY +41.65% (+850.0K)	All Managers (Combined)	$41.6M	5.7% ($41.6M/$733.1M)	QoQ -14.14% (-$6.9M) YoY +80.25% (+$18.5M)
Mineralys Therapeutics, Inc.(MLYScusip603170101)	2.5M	QoQ 0.00% (+0) YoY -22.44% (-714.9K)	All Managers (Combined)	$39.2M	5.4% ($39.2M/$733.1M)	QoQ +29.00% (+$8.8M) YoY -4.60% (-$1.9M)
OCULAR THERAPEUTIX, INC(OCULcusip67576A100)	5.3M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$39.0M	5.3% ($39.0M/$733.1M)	QoQ -14.16% (-$6.4M) YoY -19.45% (-$9.4M)
Abivax S.A.(ABVXcusip00370M103)	6.1M	QoQ 0.00% (-0) YoY +450.59% (+5.0M)	All Managers (Combined)	$37.9M	5.2% ($37.9M/$733.1M)	QoQ -14.61% (-$6.5M) YoY +140.64% (+$22.1M)
Savara Inc(SVRAcusip805111101)	12.4M	QoQ 0.00% (-0) YoY +23.62% (-2.4M)	All Managers (Combined)	$34.2M	4.7% ($34.2M/$733.1M)	QoQ -9.77% (-$3.7M) YoY -31.23% (-$15.6M)
Dyne Therapeutics, Inc.(DYNcusip26818M108)	2.7M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$27.7M	3.8% ($27.7M/$733.1M)	QoQ -55.60% (-$34.7M) YoY -63.15% (-$47.5M)
Dianthus Therapeutics, Inc. /DE/(DNTHcusip252828108)	1.5M	QoQ 0.00% (-0) YoY NEW(+1.5M)	All Managers (Combined)	$27.2M	3.7% ($27.2M/$733.1M)	QoQ -16.78% (-$5.5M) YoY NEW(+$27.2M)
Tyra Biosciences, Inc.(TYRAcusip90240B106)	2.9M	QoQ +45.69% (-909.0K) YoY +45.69% (-909.0K)	All Managers (Combined)	$27.0M	3.7% ($27.0M/$733.1M)	QoQ -2.51% (-$696.2K) YoY -17.37% (-$5.7M)
Xencor Inc(XNCRcusip98401F105)	2.5M	QoQ 0.00% (-0) YoY NEW(+2.5M)	All Managers (Combined)	$26.1M	3.6% ($26.1M/$733.1M)	QoQ -53.69% (-$30.3M) YoY NEW(+$26.1M)
Disc Medicine, Inc.(IRONcusip254604101)	465.3K	QoQ -4.45% (-21.7K) YoY NEW(+465.3K)	All Managers (Combined)	$23.1M	3.2% ($23.1M/$733.1M)	QoQ -25.19% (-$7.8M) YoY NEW(+$23.1M)
Tourmaline Bio, Inc.(TRMLcusip89157D105)	1.5M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$22.5M	3.1% ($22.5M/$733.1M)	QoQ -24.99% (-$7.5M) YoY -33.58% (-$11.4M)
Cidara Therapeutics, Inc.(CDTXcusip171757206)	1.0M	QoQ 0.00% (-0) YoY NEW(+1.0M)	All Managers (Combined)	$21.7M	3.0% ($21.7M/$733.1M)	QoQ -16.95% (-$4.4M) YoY NEW(+$21.7M)
Amylyx Pharmaceuticals, Inc.(AMLXcusip03237H101)	5.9M	QoQ +27.99% (+1.3M) YoY NEW(+5.9M)	All Managers (Combined)	$21.0M	2.9% ($21.0M/$733.1M)	QoQ +19.86% (+$3.5M) YoY NEW(+$21.0M)
SOLENO THERAPEUTICS INC(SLNOcusip834203309)	275.0K	QoQ -50.00% (-275.0K) YoY NEW(+275.0K)	All Managers (Combined)	$19.6M	2.7% ($19.6M/$733.1M)	QoQ -20.52% (-$5.1M) YoY NEW(+$19.6M)
EyePoint Pharmaceuticals, Inc.(EYPTcusip30233G209)	3.6M	QoQ 0.00% (-0) YoY NEW(+3.6M)	All Managers (Combined)	$19.4M	2.6% ($19.4M/$733.1M)	QoQ -27.24% (-$7.3M) YoY NEW(+$19.4M)
Structure Therapeutics Inc.(GPCRcusip86366E106)	1.1M	QoQ 0.00% (-0) YoY -33.49% (-535.4K)	All Managers (Combined)	$18.4M	2.5% ($18.4M/$733.1M)	QoQ -36.17% (-$10.4M) YoY -73.14% (-$50.1M)
Upstream Bio, Inc.(UPBcusip91678A107)	2.8M	QoQ 0.00% (-0) YoY NEW(+2.8M)	All Managers (Combined)	$17.1M	2.3% ($17.1M/$733.1M)	QoQ -61.77% (-$27.7M) YoY NEW(+$17.1M)
RAPT Therapeutics, Inc.(RAPTcusip75382E109)	13.1M	QoQ -0.34% (-45.1K) YoY NEW(+13.1M)	All Managers (Combined)	$16.0M	2.2% ($16.0M/$733.1M)	QoQ -19.14% (-$3.8M) YoY NEW(+$16.0M)